Patents Assigned to Med
  • Patent number: 11944568
    Abstract: The cooling system (100, 300, 400, 500, 700, 750) includes an applicator (101, 501, 701) configured to hold a predetermined amount of solid coolant and fluid coolant (117) to cool a targeted area of the body (162, 570) to crystalize the lipid-rich cells underneath the targeted area to reduce the fat cells. The applicator may include a thermoelectric cooler (TEC, 136, 704, 706) where the hot side is cooled by coolant held within the applicator. The cold side of the TEC may be thermally coupled to a cooling plate (138, 560) configured to cool a targeted area of the skin at a predetermined temperature range for a predetermined period of time. The cooling system may also be used to relieve localized pain at certain area of the body and/or utilized for cryotherapy.
    Type: Grant
    Filed: July 26, 2020
    Date of Patent: April 2, 2024
    Assignee: DIVERGENT MED LLC
    Inventor: Sung Oh
  • Publication number: 20240099823
    Abstract: A combined magnetic and bioabsorbable device for ventral hernia closure and/or tension distribution for maintenance of tissue apposition for healing, while avoiding a long-term footprint of foreign material and precluding materials spanning the interior layer of the abdominal closure where risk to visceral structures exists.
    Type: Application
    Filed: December 7, 2023
    Publication date: March 28, 2024
    Applicant: Absolutions Med, Inc.
    Inventors: Gregory LAMPS, Daniel JACOBS, Matthew Luis RIVERA, Brad RICHARDSON
  • Patent number: 11938319
    Abstract: A magnet arrangement for a hearing implant device is described. A magnet case is contained within an implantable device and has a central case axis of symmetry that is perpendicular to the outermost surface of the implantable device. The magnet case is configured to be freely rotatable within the implantable device about the case axis of symmetry. An implant magnet is contained within the magnet case and consists of a single cylindrical magnet having a central magnet axis of symmetry perpendicular to the case axis of symmetry. The implant magnet is configured to be freely rotatable within the magnet case about the magnet axis of symmetry.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: March 26, 2024
    Assignee: MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
    Inventor: Martin Zimmerling
  • Publication number: 20240094228
    Abstract: Disclosed is a method for measuring cholesterol by using a cholesterol dependent cytolysin (CDC), which is a cholesterol binding protein, and an antibody specifically recognizing HDL-C or LDL-C. The method according to the subject matter is capable of rapidly measuring low density lipoproteins and high density lipoproteins at low cost, and thus can be effectively applied in various fields requiring the measurement of low density lipoproteins and high density lipoproteins.
    Type: Application
    Filed: November 27, 2023
    Publication date: March 21, 2024
    Applicant: Boditech Med Inc.
    Inventors: Eui Yul CHOI, Do Won KIM
  • Publication number: 20240085410
    Abstract: The present disclosure relates to a diagnostic cartridge for immunodiagnosis, and a reader and a diagnostic system using the same. A diagnostic cartridge, including the diagnostic pad and the color reaction pad, is provided to detect a color reaction and a fluorescence reaction through the single diagnostic cartridge.
    Type: Application
    Filed: May 25, 2023
    Publication date: March 14, 2024
    Applicant: BODITECH MED INC.
    Inventors: Dae Gyun PARK, Minseok CHA, Ha Yong SONG
  • Publication number: 20240075043
    Abstract: An appetite suppressant composition may comprise at least one anorectic active ingredient; at least one of a nutritive substance, a cofactor; and optionally, an excipient. The anorectic active ingredient may comprise any one of phentermine, phendimetrazine, diethylpropion, naltrexone, and bupropion. The nutritive substance may comprise a protein source such as bovine collagen. The cofactor may comprise a chromium or selenium salt. In various embodiments, the compositions herein are provided in an oral capsule dosage form for GI-tract administration of the AAI. A method of suppressing appetite in individuals in need thereof are described.
    Type: Application
    Filed: November 3, 2023
    Publication date: March 7, 2024
    Applicant: Red Mountain Med Spa, LLC
    Inventor: Suzanne Bentz
  • Publication number: 20240079132
    Abstract: In an embodiment, an electronic device includes a display screen, a memory circuit, and computing circuitry, which is coupled to the display screen and to the memory circuit, and which is configured to cause the display screen to display icons that are each related to respective data regarding a patient at a medical facility, to retrieve, from the memory, the respective data in response to a user of the electronic device selecting, via the display screen, a corresponding one of the displayed icons, and to cause the display screen to display the retrieved respective data.
    Type: Application
    Filed: July 11, 2023
    Publication date: March 7, 2024
    Applicant: BFC MED LLC
    Inventors: Arun Rao, Lacey Rao
  • Publication number: 20240078665
    Abstract: A system and method of predicting propensity of metastasis of a tumor in a patient by at least one processor may include: receiving, from a first scan modality, a first scan comprising a set of scan images depicting metabolic information; receiving, from a second scan modality, a second scan comprising a set of scan images depicting anatomical information; segmenting the first scan to identify a volumetric segment representing a suspected tumor, based on the depicted metabolic information; extracting one or more radiomics features from the second scan, corresponding to the volumetric segment, based on the depicted anatomical information; and predicting propensity of metastasis of the suspected tumor, based on the one or more radiomics features.
    Type: Application
    Filed: September 1, 2023
    Publication date: March 7, 2024
    Applicant: RAMBAM MED-TECH LTD.
    Inventor: Myroslav Lutsyk
  • Patent number: 11918467
    Abstract: Annuloplasty prosthesis device (1), which is suitable for remodeling a native annulus (2), comprises a body having the shape of at least one ring portion defining a longitudinal direction, coinciding with or locally parallel to the longitudinal development direction of said body; said portion (5) being opposite to said first arcuate section (4), and the body comprises a first arcuate section (4) and at least a second segment (5); said first arcuate section (4) is flexible in a first direction, locally transverse to the longitudinal direction, so as to be deformable under flexion along said first direction; said first arcuate section (4) defines a plane of storage substantially parallel both to the longitudinal direction and to the first direction; said at least a second section (5) is rigid under flexion in said plane of storage (XY); said second section (5) is flexible in a second direction (ZZ), transverse to the plane of storage, so as to be deformable under flexion along said second direction.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: March 5, 2024
    Assignee: FONDAZIONE RI. MED
    Inventor: Gaetano Burriesci
  • Patent number: 11911476
    Abstract: The present invention relates to process for preparing a drug delivery composition comprising the steps of a) preparing a masterbatch comprising a drug and a first polymer by (i) extruding the first polymer, wherein said first polymer has a melting temperature below 140° C.; and (ii) introducing the drug during extrusion of the first polymer, with a drug content between 0.1% and 90%, based on the total weight of the masterbatch; and b) introducing the masterbatch in a polymer-based matrix during production of the drug delivery composition, wherein step a) is performed at a temperature at which the first polymer is in a partially or totally molten state, and step b) is performed at a temperature at which both the first polymer and at least a polymer of the polymer-based matrix are in a partially or totally molten state.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: February 27, 2024
    Assignee: PK MED
    Inventors: Philippe Pouletty, Frédérique Guillamot
  • Patent number: 11906520
    Abstract: The invention relates to antibodies, which bind a peptide having a sequence selected from SEQ ID NO: 2, or a fragment or derivative of such an antibody having essentially the same antigen specificity. In particular, the antibodies suited to be used to detect, manage or monitor cancer in a subject, particularly cancer with interleukin-4 induced gene 1 (IL4I1) expressing cells. The invention also relates to kits or devices containing said antibodies, suitable for immunologic detection or reaction from any biological sample.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: February 20, 2024
    Assignees: Centre National De La Recherche Scientifique, Institut National De La Sante Et De La Rech. Med., Universite Paris Est Creteil Val De Marne
    Inventors: Valérie Molinier Frenkel, Flavia Castellano
  • Publication number: 20240050418
    Abstract: In various embodiments of the present disclosure, compositions exhibiting metabolism boosting effect are described. In various examples, compositions comprise a synergistic combination of at least one plant, root, seed, or fruit material, or extract thereof, or bioactive therefrom; at least one vitamin, essential trace mineral, or enzyme or vitamin cofactor; at least one amino acid; and at least one antioxidant. In various aspects, metabolism enhancing compositions are formulated as loose powders filled into capsules as orally administered dietary supplements. In various embodiments, compositions of the present disclosure are used to treat metabolic syndrome in subjects expressing symptoms thereof.
    Type: Application
    Filed: October 26, 2023
    Publication date: February 15, 2024
    Applicant: Red Mountain Med Spa, LLC
    Inventor: Suzanne Bentz
  • Publication number: 20240050417
    Abstract: In various embodiments of the present disclosure, compositions exhibiting metabolism boosting effect are described. In various examples, compositions comprise a synergistic combination of at least one plant, root, seed, or fruit material, or extract thereof, or bioactive therefrom; at least one vitamin, essential trace mineral, or enzyme or vitamin cofactor; at least one amino acid; and at least one antioxidant. In various aspects, metabolism enhancing compositions are formulated as loose powders filled into capsules as orally administered dietary supplements. In various embodiments, compositions of the present disclosure are used to treat metabolic syndrome in subjects expressing symptoms thereof.
    Type: Application
    Filed: August 10, 2022
    Publication date: February 15, 2024
    Applicant: Red Mountain Med Spa, LLC
    Inventor: Suzanne Bentz
  • Patent number: 11896524
    Abstract: A tissue removal device includes a hollow needle, an ultrasonic transducer for mechanically vibrating the needle, an aspiration line communicating with the needle, and a vacuum pulsing device for generating vacuum pulses in the needle. The device may be utilized for breaking up tissue by phacoemulsification, vacuum pulsing, or both.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: February 13, 2024
    Assignee: Med-Logics, Inc.
    Inventors: Rodney L. Ross, James Dennewill
  • Patent number: 11896598
    Abstract: An appetite suppressant composition may comprise at least one anorectic active ingredient; at least one of a nutritive substance, a cofactor; and optionally, an excipient. The anorectic active ingredient may comprise any one of phentermine, phendimetrazine, diethylpropion, naltrexone, and bupropion. The nutritive substance may comprise a protein source such as bovine collagen. The cofactor may comprise a chromium or selenium salt. In various embodiments, the compositions herein are provided in an oral capsule dosage form for GI-tract administration of the AAI. A method of suppressing appetite in individuals in need thereof are described.
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: February 13, 2024
    Assignee: RED MOUNTAIN MED SPA, LLC
    Inventor: Suzanne Bentz
  • Patent number: 11891727
    Abstract: Thermally stable absorbable fiber populations, i.e. fiber populations that do not undergo thermally induced crystallization, can be intermixed with thermally unstable fibers to yield a stabilizing effect without altering morphological properties of a fiber system. Via this, one may minimize thermally induced shrinkage and maintain physical properties of electrospun materials in the as-formed state.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: February 6, 2024
    Assignee: Poly-Med, Inc.
    Inventors: Michael Scott Taylor, Seth Dylan McCullen
  • Patent number: 11890331
    Abstract: The present disclosure discloses compositions comprising a hyaluronidase, devices comprising such compositions, as well as methods and uses employing such compositions and devices to reduce or eliminate a hyaluronic acid-induced blockage of one or more blood vessels supplying an eye of an individual; methods and uses for employing such compositions and devices to reduce or inhibit a vascular occlusion in an eye of an individual; and methods and uses for employing such compositions and devices to reduce or inhibit a hyaluronic acid-induced loss of vision of an individual.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: February 6, 2024
    Assignee: Med Progress, LLC
    Inventor: Steve Yoelin
  • Publication number: 20240032702
    Abstract: An interactive headboard system includes an interactive headboard configured to be attached to a bedframe. The interactive headboard comprises a video screen, and optionally one or more additional sensory output devices such as for example, one or more speakers, fans, scent ports, and/or motion actuators. The system may aid in the immersion of a viewer within the images presented on the video screen, helping them to relax. The system may also comprise a bed frame and/or an interactive footboard.
    Type: Application
    Filed: July 26, 2023
    Publication date: February 1, 2024
    Applicant: CHAP-MED, INC.
    Inventor: James L. CHAPPUIS
  • Publication number: 20240038098
    Abstract: A simulator apparatus for training medical professionals in the procedures of chest tube insertion and/or pericardiocentesis. The apparatus includes a first stand element and a second stand element that form a rib panel base with the two elements substantially at right angles to one another to create a 90-degree stand. A rib panel is removably joined to the two stand elements and includes curved slots representing the spaces between ribs. This allows for the insertion of chest tubes between the simulated rib spaces, using off-the-shelf supplies to create a subcutaneous and skin overlay. For training in pericardiocentesis, the rib panel can be placed on a standard dimension medical basin, which is filled with a training heart with a pericardial effusion created with off-the-shelf supplies. The basin is then filled with echogenic material (water, water and fiber supplement, or gelatin) that facilitates ultrasound.
    Type: Application
    Filed: December 3, 2021
    Publication date: February 1, 2024
    Applicant: HALO Med LLC
    Inventor: Jason F Hine
  • Patent number: D1014749
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: February 13, 2024
    Assignee: Bio Med Pro LLC
    Inventor: Michael Nasr